BLTE Belite Bio, Inc.
Fundamentals / CIK 0001889109 / USDBelite Bio, Inc. reported $780.6M in total assets and a net loss of $77.61M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BLTE in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$84.21M Operating profit
-
Net Income FY 2025-$77.61M GAAP bottom line
-
Diluted EPS FY 2025-$2.31 Split-adjusted
-
Free Cash Flow FY 2025-$37.06M Operating CF less CapEx
-
Cash & ST Investments Dec 31, 2025$352.9M Total debt: $429K
Annual revenue and net income
6 fiscal years (2020 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Research & Development | $45.38M | $29.94M | $24.84M | $8.87M | $7.42M | $3.69M |
| Selling, General & Admin | $38.83M | $10.06M | $6.82M | -- | -- | -- |
| Total Operating Expenses | $84.21M | $40.00M | $31.67M | $12.82M | $9.80M | $5.74M |
| Operating Income | -$84.21M | -$40.00M | -$31.67M | -$12.82M | -$9.80M | -$5.74M |
| EBITDA | -$84.02M | -$39.83M | -$31.53M | -$12.76M | -$9.77M | -$5.73M |
| Interest Income | $6.64M | $3.74M | $74K | $23K | $5.0K | $12K |
| Interest Expense | $2.0K | $20K | $25K | $16K | -- | $21K |
| Income Before Tax | -$77.61M | -$36.14M | -$31.62M | -$12.65M | -$9.67M | -$5.75M |
| Income Tax Expense | $0 | $6.0K | $9.0K | -- | -- | $1.0K |
| Net Income | -$77.61M | -$36.14M | -$31.63M | -$12.65M | -$9.67M | -$5.75M |
| Basic EPS | -$2.31 | -$1.18 | -$1.19 | -$0.63 | -$1.01 | -$0.65 |
| Diluted EPS | -$2.31 | -$1.18 | -$1.19 | -$0.63 | -$1.01 | -$0.65 |
| Basic Shares Outstanding | 33.5M | 30.5M | 26.6M | 20.0M | 9.6M | 8.8M |
| Diluted Shares Outstanding | 33.5M | 30.5M | 26.6M | 20.0M | 9.6M | 8.8M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $352.9M | $31.68M | $88.16M | $42.09M | $17.34M |
| Short-Term Investments | -- | $4.55M | -- | -- | -- |
| Cash & Short-Term Investments | $352.9M | $36.23M | $88.16M | $42.09M | $17.34M |
| Other Current Assets | $5.0K | -- | -- | -- | -- |
| Total Current Assets | $494.3M | $147.1M | $89.94M | $42.81M | $17.43M |
| Property, Plant & Equipment, Net | $344K | $444K | $490K | $541K | $94K |
| Intangible Assets | $19K | $31K | -- | -- | -- |
| Total Non-Current Assets | $286.3M | $5.06M | $4.70M | $1.47M | $917K |
| Total Assets | $780.6M | $152.1M | $94.64M | $44.27M | $18.35M |
| Other Current Liabilities | $5.0K | $13K | -- | -- | -- |
| Total Current Liabilities | $9.88M | $6.05M | $3.63M | $2.10M | $1.64M |
| Total Non-Current Liabilities | $188K | $261K | $578K | $668K | $0 |
| Total Liabilities | $10.07M | $6.31M | $4.21M | $2.77M | $1.64M |
| Total Debt (incl. Leases) | $429K | $537K | $886K | $866K | -- |
| Common Stock | $4.0K | $3.0K | $3.0K | $3.0K | $1.0K |
| Retained Earnings | -$185.3M | -$107.6M | -$71.50M | -$39.87M | -$27.22M |
| Accumulated Other Comp. Income | -$536K | -$660K | -$374K | -$392K | -$196K |
| Total Stockholders' Equity | $770.5M | $145.8M | $90.43M | $41.50M | -$15.09M |
| Total Equity | $770.5M | $145.8M | $90.43M | $41.50M | -$15.09M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $352.9M | $31.68M | $88.16M | $42.09M | $17.34M |
| Short-Term Investments | -- | $4.55M | -- | -- | -- |
| Cash & Short-Term Investments | $352.9M | $36.23M | $88.16M | $42.09M | $17.34M |
| Other Current Assets | $5.0K | -- | -- | -- | -- |
| Total Current Assets | $494.3M | $147.1M | $89.94M | $42.81M | $17.43M |
| Property, Plant & Equipment, Net | $344K | $444K | $490K | $541K | $94K |
| Intangible Assets | $19K | $31K | -- | -- | -- |
| Total Non-Current Assets | $286.3M | $5.06M | $4.70M | $1.47M | $917K |
| Total Assets | $780.6M | $152.1M | $94.64M | $44.27M | $18.35M |
| Other Current Liabilities | $5.0K | $13K | -- | -- | -- |
| Total Current Liabilities | $9.88M | $6.05M | $3.63M | $2.10M | $1.64M |
| Total Non-Current Liabilities | $188K | $261K | $578K | $668K | $0 |
| Total Liabilities | $10.07M | $6.31M | $4.21M | $2.77M | $1.64M |
| Total Debt (incl. Leases) | $429K | $537K | $886K | $866K | -- |
| Common Stock | $4.0K | $3.0K | $3.0K | $3.0K | $1.0K |
| Retained Earnings | -$185.3M | -$107.6M | -$71.50M | -$39.87M | -$27.22M |
| Accumulated Other Comp. Income | -$536K | -$660K | -$374K | -$392K | -$196K |
| Total Stockholders' Equity | $770.5M | $145.8M | $90.43M | $41.50M | -$15.09M |
| Total Equity | $770.5M | $145.8M | $90.43M | $41.50M | -$15.09M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Net Income | -$77.61M | -$36.14M | -$31.63M | -$12.65M | -$9.67M | -$5.75M |
| Depreciation & Amortization | $184K | $168K | $139K | $64K | $30K | $17K |
| Stock-Based Compensation | $38.92M | $8.99M | $3.82M | $1.48M | $1.53M | $1.36M |
| Operating Cash Flow | -$36.99M | -$29.23M | -$29.84M | -$11.46M | -$7.47M | -$4.44M |
| Capital Expenditure | -$71K | -$116K | -$63K | -$394K | -$74K | -- |
| Free Cash Flow | -$37.06M | -$29.35M | -$29.90M | -$11.85M | -$7.55M | -- |
| Purchases of Investments | -- | -$4.50M | -- | -- | -- | -- |
| Sales & Maturities of Investments | -- | $77.84M | -- | -- | -- | -- |
| Investing Cash Flow | -$305.1M | -$110.6M | -$63K | -$394K | -$56K | -$20K |
| Common Stock Issued | -- | -- | -- | -- | -- | $500K |
| Financing Cash Flow | $663.2M | $83.59M | $75.96M | $36.96M | -$583K | $28.06M |
| Net Change in Cash | $321.3M | -$56.48M | $46.07M | $24.75M | -$8.27M | $23.60M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -10.1% | -24.8% | -35.0% | -30.5% | -- | -- |
| Return on Assets (ROA) | -9.9% | -23.8% | -33.4% | -28.6% | -52.7% | -- |
| Current Ratio | 50.02x | 24.31x | 24.76x | 20.35x | 10.66x | -- |
| Quick Ratio | 35.71x | 5.99x | 24.27x | 20.00x | 10.61x | -- |
| Debt to Equity | 0.00x | 0.00x | 0.01x | 0.02x | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.